- .
- eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention..
"she was our mother, the anchor and heartbeat to our family," derek said. "(she) would spread her love and dedication like a small hummingbird.".
david dodick, md, neurologist, mayo clinic; chairman, american migraine foundation..
media won�t investigate medically-caused death numbers..
.